Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Robot Therapy for Rehabilitation of Hand Movement After Stroke (HEXORR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04536987
Recruitment Status : Completed
First Posted : September 3, 2020
Last Update Posted : September 3, 2020
Sponsor:
Collaborator:
MedStar National Rehabilitation Network
Information provided by (Responsible Party):
The Catholic University of America

Brief Summary:
A study will be performed where individuals with chronic stroke will be randomly assigned to receive 2 different dosages of robotic hand therapy. One group will receive 12 sessions of robot-assisted repetitive movement practice in the HEXORR robot over a 4-5 week period. A second group will receive 24 sessions of HEXORR therapy over a 8-10 week period.

Condition or disease Intervention/treatment Phase
Stroke Movement Disorders Hemiparesis Device: HEXORR Phase 2

Detailed Description:
The overall goal of the proposed work is to improve hand function after stroke. Adequate hand function is critical to a functional upper limb, and is often resistant to conventional therapeutic interventions. Many stroke survivors have residual ability to flex the fingers, but extension is often limited and impeded by increased passive stiffness in flexors, involuntary activation of flexors and inability to activate extensors. The rationale for this approach stems from the growing evidence that neuro-rehabilitation after stroke may be enhanced via the application of motor learning strategies within the context of repetitive movement practice. The key therapeutic aspects of these strategies are high repetition, volitional effort, and successful completion of tasks to prevent frustration. While these represent promising therapeutic strategies, they are limited to mildly impaired subjects who already have enough control of finger extension to tolerate high repetitions of grasp/release tasks without succumbing to fatigue and/or frustration. There is a very large population of stroke patients who don't fall into this category and often must rely on compensatory strategies. In these patients, repetitive task practice facilitated by a robotic device may be more effective than unassisted task practice.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Random assignment to two study groups
Masking: Single (Outcomes Assessor)
Masking Description: Staff performing clinical evaluations was unaware of the study design.
Primary Purpose: Treatment
Official Title: Robot Therapy for Rehabilitation of Hand Movement After Stroke
Actual Study Start Date : October 4, 2012
Actual Primary Completion Date : January 15, 2017
Actual Study Completion Date : January 15, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Experimental: low-dosage robot therapy
12 sessions of robotic therapy over 4-5 weeks
Device: HEXORR
The subject receives robotic assistance from the HEXORR robot during finger and thumb movements. Several different video games are used to provide feedback of performance and motivate the training. The assistance level is adjusted automatically in some games and manually in other games to enable a target success rate of 67% when playing the games.

Experimental: hi-dosage robot therapy
24 sessions of robotic therapy over 8-10 weeks
Device: HEXORR
The subject receives robotic assistance from the HEXORR robot during finger and thumb movements. Several different video games are used to provide feedback of performance and motivate the training. The assistance level is adjusted automatically in some games and manually in other games to enable a target success rate of 67% when playing the games.




Primary Outcome Measures :
  1. Change in Fugl-Meyer Test of Motor Function [ Time Frame: 6 month follow-up ]
    Measures motor impairment in the upper extremity after stroke


Secondary Outcome Measures :
  1. Change in Action Research Arm Test [ Time Frame: 6 month follow-up ]
    Measures functional limitations of the upper extremity

  2. Change in finger extension range of motion (degrees) [ Time Frame: 6 month follow-up ]
    Motion capture of finger and thumb movement will be used to assess extension ability in units of degrees. The task will be to open the hand as far as possible from a closed fist. Data from all digits will be averaged to provide a single metric for extension ability of the fingers and thumb.

  3. Change in Modified Ashworth Test [ Time Frame: 6 month follow-up ]
    Measures hypertonia in the flexors of the fingers, wrist and elbow joints

  4. Change in Motor Activity Log [ Time Frame: 6 month follow-up ]
    Measures the amount of use of the upper extremity in ADL

  5. Change in Grip Strength [ Time Frame: 6 month follow-up ]
    Jamar Dynamometer



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. a diagnosis of stroke more than 6 months prior to randomization
  2. presence of voluntary hand activity indicated by a score of at least 1 on the finger mass extension/grasp release item of the Fugl-Meyer Test of Motor Function
  3. adequate cognitive status, as determined by Mini-Mental Status Examination score >24

Exclusion Criteria:

  1. were under the influence of oral or injected antispasticity medications during the study
  2. had MCP and IP passive extension limit > 30 degrees from full extension
  3. had pain that interfered with daily activities
  4. had excessive tone in the fingers and thumb as determined by Ashworth scores >=3
  5. had severe sensory loss or hemispatial neglect as determined by clinical exam.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04536987


Locations
Layout table for location information
United States, District of Columbia
MedStar National Rehabilitation Network
Washington, District of Columbia, United States, 20010
Sponsors and Collaborators
The Catholic University of America
MedStar National Rehabilitation Network
Investigators
Layout table for investigator information
Principal Investigator: Peter Lum The Catholic University of America
Publications:
Layout table for additonal information
Responsible Party: The Catholic University of America
ClinicalTrials.gov Identifier: NCT04536987    
Other Study ID Numbers: 2012-315
First Posted: September 3, 2020    Key Record Dates
Last Update Posted: September 3, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plan to share data.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by The Catholic University of America:
robotic therapy
finger
hand
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Movement Disorders
Paresis
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Neurologic Manifestations